Reportlinker Adds Global Veterinary Vaccines Industry

Mar 22, 2011, 06:52 ET from Reportlinker

NEW YORK, March 22, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Veterinary Vaccines Industry

http://www.reportlinker.com/p092485/Global-Veterinary-Vaccines-Industry.html

This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product segments - Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 69 companies including many key and niche players such as Bayer HealthCare AG, Biogenesis-Bago, Boehringer Ingelheim GmbH, Heska Corporation, Imugene Limited, Indian Immunologicals Ltd., Lohmann Animal Health, Merck & Co., Inc., Intervet/Schering-Plough Animal Health, Merial Ltd., Pfizer, Inc., Embrex, Inc., Fort Dodge Animal Health, Protein Sciences Corporation, and Virbac Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definitions and Scope of Study 3

A. Companion Animal Vaccines 4

B. Livestock Vaccines 4

Porcine Vaccines 4

Bovine Vaccines 4

Poultry Vaccines 4

Ovine Vaccines 4

Equine Vaccines 5

Other Animal Vaccines 5

2. INDUSTRY OVERVIEW & OUTLOOK 6

Global Animal Health Care Industry - A Brief Review 6

Table 1: Global Animal Health Products Market by Region

(2008): Percentage Share Breakdown by Value Sales for North

America, Europe, Latin America and Rest of World (includes

corresponding Graph/Chart) 6

Table 2: Global Animal Health Products Market by Product

Group (2008): Percentage Share Breakdown by Value sales for

Parasiticides, Vaccines, Anti-Infectives, Medical Feed

Additives and Other Pharmaceuticals (includes corresponding

Graph/Chart) 6

Animal Healthcare Market Grows Amidst Recession 7

Veterinary Vaccines Industry Posts Moderate Growth 7

Poultry Vaccines Industry: A Global Scenario 7

Improved Manufacturing Techniques 8

Improved Analysis 8

Scope of the Report 8

3. MARKET TRENDS & ISSUES 9

Companion Animal Vaccines: Trailing on a High Growth Track 9

OTC Market: A Potential Threat for Veterinarians 9

Small Animal Practitioners Feel the Pinch of Recession 9

Parasiticides, Systemic Agents To Drive The Market 9

Taxonomy of Vaccines 9

Bird Flu - The Aftermath 10

Vaccination - Critical for Controlling Avian Influenza Virus 10

4. PRODUCT OVERVIEW 11

Vaccines - An Evolutionary Scan 11

Contribution of Animal Research to Vaccine Production 11

Veterinary Medicines- A Brief Review 12

Preventive Medicines 12

Therapeutic Medicines 12

Others 12

Development of Vaccines 12

Production of Vaccines 13

Veterinary Vaccines - An Essential Component of Animal Health

Care 13

What Does A Veterinary Vaccine Do? 14

Classification of Veterinary Vaccines 14

Companion Animals Vaccines 14

Canine Vaccines 14

Feline Vaccines 16

Livestock Vaccines 17

Bovine Vaccines 17

Poultry Vaccines 18

Ovine Vaccines 18

Porcine Vaccines 19

Equine Vaccines 19

Aquaculture Vaccines 19

A Tabular Analysis on Select Animal Diseases Controlled by

Vaccines 20

Vaccination and Its Reactions 20

Veterinary Vaccines- Latest Breakthroughs 20

Marker vaccines 20

DNA vaccines 20

Gene-deleted vaccines 21

Viral-vectored vaccines 21

5. NOTES ON SELECT ANIMAL DISEASES 22

Brucellosis 22

Tuberculosis 22

Johne's disease 22

Spirochete Associated Diseases 22

Respiratory Disease in Goats, Sheep, and Cattle 23

Porcine Respiratory Diseases 23

Mastitis 23

African Swine Fever 23

Avian Influenza 24

East Coast Fever 24

Hemorrhagic Septicemia 24

Foot-And-Mouth Disease 24

Japanese Encephalitis 24

Rift Valley Fever 25

Equine Virus 25

6. PRODUCT INNOVATIONS/INTRODUCTIONS 26

Intervet/Schering-Plough Animal Health Introduces a New Web

Site for Innovax recombinant Vaccines Product Line 26

Pfizer Animal Health Introduces the First E. Coli Bacterial

Extract Vaccine 26

Intervet Schering-Plough Animal Health Re-Launches EQUILIS®

StrepE for Horses 26

Boehringer Ingelheim Vetmedica Launches Single Shot 3FLEX

combination package PL 26

Pfizer Animal Health Launches INFORCE™ 3 26

Boehringer Ingelheim Introduces Ingelvac CircoFLEX® in Russia 27

Pfizer Animal Health Introduces Bopriva® for Bull and Beef

Market in NZ 27

GALVmed, Inter-African Bureau for Animal Resources Launch ECF

Vaccine 27

BIVI launches Five New Variants of Vetera® Vaccines 28

Hipra Announces Launch of Suiseng® 28

Aceto Corporation Receives Approval to Sell Suppliera[euro]™

in the US 28

Intervet Schering-Plough Unleashes NOBIVAC Lyme Vaccine for Dogs 29

Intervet Schering-Plough Animal Health Introduces PORCILIS PCV

Vaccine 29

Lohmann Launches AviPro® MEGAN®VAC Vaccination for Salmonella

Disease 29

Intervet Schering Plough Animal Health Introduces Circovirosis

Vaccine 29

Pfizer Animal Health Develops Inovocox® Vaccine 29

Intervet/Schering-Plough Animal Health Launches Bravoxin 10 30

Bioject and Merial Rolls Out Derma-Vac NF 30

Defra to Launch Bovine Tuberculosis Vaccine 30

Intervet International Develops Bluetongue Vaccine 31

Hester Biosciences Unveils Anti-Coryza Vaccine 31

Intervet/Schering-Plough Animal Health Introduces Bovilis BTV8

Vaccine 31

Tecnovax Develops Vaccine for Salmon Virus 31

Tamil Nadu Veterinary and Animal Science University and The

Indian Veterinary Research Institute Develop Vaccine 31

Lohmann Animal Health Develops AviPro IBD Xtreme 31

Intervet/Schering-Plough Animal Health Launches EquiRab™ 32

Lohmann Animal Health Introduces Larger Doses of AviPro®

ViBursa CE 32

Lohmann Animal Health International Rolls Out AviBlue 32

Fort Dodge Animal Health Unveils West Nile-Innovator DNA 33

Univet Agricultural Products Introduces Coglapest 33

Intervet/Schering-Plough Animal Health Launches Porcilis® COLI 6C 33

Pfizer Animal Health Unveils FluSure® XP Defense System 33

Pfizer Animal Health Launches Improvac® 34

Intervet/Schering-Plough Animal Health Develops Onset™ 5

Intranasal (IN) Vaccine 34

Merial Rolls Out BTVPUR AlSap 8 34

Pfizer Animal Health Introduces FarrowSure® GOLD and

FarrowSure® GOLD B 35

Schering-Plough Animal Health Unveils CAVALRY 9 35

Lohmann Animal Health Develops BTO2 REO Vaccine 35

7. PRODUCT INNOVATIONS/INTRODUCTIONS IN RECENT PAST - A

PERSPECTIVE BUILDER 36

Agroinsuvet Introduces New Vaccines 36

Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for

Poultry Industry 36

Intervet & Friedrich-Loeffler-Institute Develop Dual Vaccine

Prototype for Birds 36

Schering-Plough Receives USDA License for its Rhusigen™

Erysipelas Vaccine 36

USDA Approves Use of PreveNile™ Vaccine for Horses 37

Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine 37

Boehringer Ingelheim's Swine Vaccine Gains Approval in Australia 37

Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma

in Dogs 37

Embrex's Poultry Vaccine Inovocox Gets USDA Approval 38

Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine 38

United States Department of Agriculture Grants Conditional

License for Necrotic Enteritis Vaccine 38

Fort Dodge Receives USDA License for Pyramid®10 39

USDA Licenses Use of Fort Dodge's Suvaxyn® PCV2 Vaccine in Pigs 39

USDA Grants Conditional License to Pfizer's New Canine Vaccine 39

8. RECENT INDUSTRY ACTIVITY 40

Centegen Enters into Licensing Partnership with Merial 40

The Ugandan Government Enters into Partnership with Brentec

Vaccines International 40

Pfizer Animal Health Kicks Off Equine Business Unit 40

Pfizer Animal Health Acquires Microtek 40

GenVec Enters into Collaboration with Merial to Develop and

Commercialize FMD Vaccine 41

Pfizer Animal Health Inks Global Licensing Deal with Epitopix 41

Indian Immunologicals Intends to Establish a New Facility in

Hyderabad 41

Pfizer Phases out Animal Vaccine Manufacturing Unit of Wyeth

in the Netherlands 41

Vivalis Signs Commercial License for EB66® Cell Line Platform 42

Ibio Grants Rights of iBioLaunch platform to Government Funded

Project 42

Intervet/Schering-Plough Animal Health Unveils Production

Center at Boxmeer 42

Globion India Announced Plans to Develop Eight New Vaccines 42

Veterinary Services Department Intends to Upgrade VRI 42

VIVALIS Grants Rights of EB66® Cell Line To KYOTO BIKEN 43

Vical Enters Into Agreement with GenomIdea for Development of

DNA Vaccine 43

Intervet/Schering-Plough Animal Health Unveils the New Freeze

-drying and Specialized Central Filling Unit 43

Him Electronics Enters into Partnership with Hester Bioscience

to Produce Animal Vaccines 44

Intervet/Schering-Plough Animal Health Receives Approval for

Nobivac Lepto4 44

Biolex Enters into Collaboration With Merial for Research and

Development 44

Intervet/Schering-Plough Animal Health Receives Full License

from USDA for Nobivac® Vaccine 45

Intercell Inks License Agreement with Boehringer 45

Intervet/Schering-Plough Recalls PreveNile West Nile Virus

Vaccine in the US 45

Merial Gains Full License of ONCEPT™ from USDA 45

Virbac Acquires Veterinary Assets from Pfizer 46

Harbin Pharmaceutical Group Holding Acquires Animal Vaccine

Business From Pfizer 46

Boehringer Ingelheim Acquires Certain Cattle Vaccines from

Fort Dodge 46

Virbac Acquires 30% Share in Santa Elena 46

Merck and Sanofi-Aventis to Merge their Animal Health Business 46

Elanco to Take Over Pfizer's Animal Health Products Portfolio 47

Boehringer Ingelhei to Acquire Pfizer's Fort Dodge Animal

Health Unit 47

ImmunoVaccine Inks Deal with Pfizer 47

Merck Merges with Schering-Plough 48

Pfizer Acquires Wyeth 48

Merial Receives Marketing License for BTVPUR AlSap 8 Vaccine 48

Epitopix Obtains Approval to Sell Siderophore Receptor and

Porin Vaccine 48

Phibro Animal Health Acquires Animal Health Division of Abic 49

Fort Dodge Animal Health and Vivalis Sign Commercial License Deal 49

Hester Biosciences Expands Gujarat Based Facility 49

Intervet/Schering-Plough Animal Health Replaces Bovilis® IBR

Vaccine with Bovilis® IBR Marker Live 50

Tangshan Yian Biological Engineering Wins Approval from

Ministry of Agriculture of China 50

Lohmann Animal Health International Signs an Agreement with

Celldex Therapeutics 50

Intervet/Schering-Plough Animal Health Starts New

Manufacturing Facility 50

Laprovet Commences New Facility 51

ImmunoVaccine Technologies and La Jolla Institute for Allergy

& Immunology Enter into an Agreement 51

Merial Signs a Toll Distribution and Manufacturing Agreement

with Newport Laboratories 51

BOEHRINGER INGELHEIM Animal Health Signs Research License Deal

with Vivalis 52

AviTech Selects Merial as a Distributor and Service Provider 52

Bayer Inks Agreement with Juvaris 52

Pfizer Inks Agreement with ImmunoVaccine Technologies 52

BioVet Inaugurates BSL-4 Production Unit in India 53

Vaxine to Take over Protein Sciences 53

Pfizer Inaugurates a New Development Facility for Veterinary

Vaccines 53

Merial to Establish Animal Vaccine Manufacturing Plant 53

BNC Bioniche Life Sciences Bags Approval to Sell Econiche

Vaccines 53

Hind Bio-Pharmaceuticals to Establish Animal Vaccines Division 54

Pfizer's Animal Health Unit Acquires Schering-Plough's Product

License in Europe 54

Grupo Mathiesen Takes Over Centro de Diagnostico Veterinario 54

Harbin Veterinary Research Institute Opens Animal Vaccine

Manufacturing Base 54

Bioject Medical Technologies Enters into a Long-Term Supply,

Development and License Contract with Merial 55

Vivalis SA Signs Letter of Intent with Intervet/ Schering-Plough 55

Biochemiq Enters into Partnership with Labovet 55

Microbix Biosystems Purchases Production Plant 55

Beijing Veterinary Biological Product Factory Starts Operation

in New Plant 55

Changzhou Tongtai Biopharmaceutical Sets Up Rabies Vaccine

Facility 56

Schering-Plough to Sell Health Products of Animals to Pfizer

and Virbac 56

Pfizer Group Establishes a Veterinary Vaccines Development Center 56

Phylaxia to Acquire Gazdasagi Radio and Kozep-europai

Gazterminal Zrt 56

Bayer HealthCare AG's Animal Health Unit Enters into Licensing

Agreement with Juvaris BioTherapeutics 57

Vivalis Enters into a Commercial License Contract with Virbac 57

ImmunoVaccine Technologies Signs Licensing Agreement with

Pfizer Animal Health 57

Kaketsuken and Vivalis Extends Research Collaboration 57

Heska Amends Distribution Contract with Agri Laboratories 57

Prevtec Microbia and Saskatchewan Research Council Receives

Approval to Market and Manufacture Coliprotec 58

Imugene and Merial Enter into an Agreement 58

Celldex Therapeutics Merges with AVANT Immunotherapeutics'

Subsidiary 58

Ceva Sante Animale Acquires Delvet 58

Inovio Biomedical Signs Merger Agreement with VGX Pharmaceuticals 59

Environmental Risk Management Authority Approves equine

Influenza Vaccine 59

Functional Technologies Commences Operations of Phyterra Bio 59

Summit VetPharm Enters into Distribution Partnership with

Webster Veterinary Unit 59

PerOs Receives Establishment and Bacterin License from USDA 60

Wyeth's Fort Dodge Animal Health Unit Acquires Poultry Vaccines 60

Boehringer Ingelheim Vetmedica Receives Approval for Express®

FP and Express® Vaccines from the USDA 60

9. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 61

Merial Bags Major Australian Contract 61

United States Department of Agriculture Approves Intervet Vaccine 61

Merial Pockets Ancare 61

Heska Revises Distribution Agreement with AgriLabs 61

Animal Health International Acquires Kane Veterinary Supplies 62

Industrial Equity Investments Pockets Arysta LifeScience 62

Henry Schein Acquires W&J Dunlop 62

Tecnovax Establishes New Facility 62

Pingtung Agricultural to Set Up an Exclusive Veterinary Park 62

Ouro Fino To Expand Veterinary Product Suite 62

Alpharma Acquires Yantai Jinhai 62

Pfizer Animal Health Acquires Embrex 63

Schering-Plough Acquires Intervet 63

Schering-Plough Acquires Organon BioSciences 63

Intervet Sets Up New Animal Vaccine Production Facility in

Boxmeer 63

Crucell Licenses PER.C6® Technology to Pfizer Animal Health 64

Central Veterinary Research Laboratory to Synthesize New

Animal Vaccines 64

Pfizer to Shut Down Omaha Animal Vaccine Center 64

IGI Licenses Novasomes to Novavax 65

Bogor Agricultural Institute Collaborates with Shigeta Animal

Pharmaceuticals 65

Suguna Poultry Steps into Livestock Vaccine Production Business 65

European Medicines Agency Grants Community Authorization for

Nobilis Influenza H7N1 65

AVANT Immunotherapeutics & Pfizer Collaborate to Develop

Animal Vaccines 66

Intervet International Acquires FMD Vaccine Production

Facility from Bayer Healthcare 66

Canadian Food Inspection Agency Authorizes Bioniche E. Coli

O157:H7 Cattle Vaccine for Field Use 66

Hemispherx Biopharma Acquires DOGS Molecule Patent 67

Hind Industries to Establish Animal Vaccine Formulations Plant

at Patiala 67

Cryosite and Animal Health Australia Form Partnership 67

Hester Pharmaceuticals Plans Capacity Expansion 67

Biovet to Set up Animal Vaccine Plant in Karnataka 67

Bogor Institute of Agricultureand Shigeta Establish JV for

Production of CLOSE 5.1 Vaccine 67

IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune 68

Bioject Medical Technologies Signs Three Agreements WithMerial 68

PetCARE Television Network signs Distribution Agreement with

Butler Animal Health Supply 68

Poultry Vaccine to be produced in Vladimir 68

10. RESEARCH AND DEVELOPMENT IN RECENT PAST 69

Scientists Develop New Vaccine Against Disease Related to PCV2 69

Auburn University and Vaxin Researchers Develop Avian Flu Vaccine 69

UK Researchers Develop In-Shell Vaccine for Chicks 69

Researchers in Vietnam Decode the H5N1 Virus Gene 70

Pittsburgh Researchers Create Avian Flu Vaccine from H5N1 Virus 70

University of Warwick Develops Protecting Virus Method 70

New Treatment Measure Against Ovine Salmonella & Brucellosis 71

ICAR Develops Indigenous Bird Flu Vaccine 71

St. Jude Develops Flu Virus Vaccine through Reverse Genetics 71

Researchers Develop Vaccine for Swine Disease 71

Researchers Develop Experimental Vaccine Against 1918

Influenza Virus 72

Study Proves Effectiveness of Intradermal Vaccine

Administration in Rabbits 72

CEL-SCI's CEL-1000 Peptide Shows Adjuvant Activity 73

Progress in Vaccine for Canine Cancer 73

11. FOCUS ON SELECT GLOBAL PLAYERS 74

Bayer HealthCare AG (Germany) 74

Biogenesis-Bago (Argentina) 74

Boehringer Ingelheim GmbH (Germany) 74

Heska Corporation (US) 75

Imugene Limited (Australia) 75

Indian Immunologicals Ltd (India) 75

Lohmann Animal Health (US) 76

Merck & Co., Inc. (US) 76

Intervet/Schering-Plough Animal Health (The Netherlands) 77

Merial Ltd. (US) 77

Pfizer, Inc. (US) 77

Embrex, Inc. (US) 78

Fort Dodge Animal Health (US) 78

Protein Sciences Corporation (US) 79

Virbac Corporation (US) 79

12. GLOBAL MARKET PERSPECTIVE 80

Table 3: World Recent Past, Current & Future Analysis for

Veterinary Vaccines by Geographic Region - US, Europe and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 80

Table 4: World Historic Review Veterinary Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 81

Table 5: World 11-Year Perspective for Veterinary Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015(includes corresponding Graph/Chart) 82

Table 6: World Recent Past, Current & Future Analysis for

Companion Animal Vaccines by Geographic Region - US, Europe

and Rest of World Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 83

Table 7: World Historic Review for Companion Animal Vaccines

by Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 84

Table 8: World 11-Year Perspective for Companion Animal

Vaccines by Geographic Region - Percentage Breakdown of Dollar

Sales for US, Europe and Rest of World Markets for Years 2005,

2010 & 2015 (includes corresponding Graph/Chart) 85

Table 9: World Recent Past, Current & Future Analysis for

Companion Animal Vaccines by Product Segment- Canine Vaccines&

Feline Vaccines Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 86

Table 10: World Historic Review for Companion Animal Vaccines

by Product Segment- Canine Vaccines & Feline Vaccines Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 87

Table 11: World 11-Year Perspective for Companion Animal

Vaccines by Product Segment - Percentage Breakdown of Dollar

Sales for Canine Vaccines & Feline Vaccines Markets for Years

2005, 2010 & 2015 87

Table 12: World Recent Past, Current & Future Analysis for

Canine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 88

Table 13: World Historic Review for Canine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 89

Table 14: World 11-Year Perspective for Canine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 90

Table 15: World Recent Past, Current & Future Analysis for

Feline Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 91

Table 16: World Historic Review for Feline Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 92

Table 17: World 11-Year Perspective for Feline Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015(includes corresponding Graph/Chart) 93

Table 18: World Recent Past, Current & Future Analysis for

Livestock Vaccines by Geographic Region - US, Europe and Rest

of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 94

Table 19: World Historic Review for Livestock Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 95

Table 20: World 11-Year Perspective for Livestock Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 96

Table 21: World Recent Past, Current & Future Analysis for

Livestock Vaccines by Product Segment - Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine

Vaccines and Other Animal Vaccines Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2007 through 2015 (includes corresponding Graph/Chart) 97

Table 22: World Historic Review for Livestock Vaccines by

Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry

Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal

Vaccines Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 98

Table 23: World 11-Year Perspective for Livestock Vaccines by

Product Segment - Percentage Breakdown of Dollar Sales for

Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines & Other Animal Vaccines Markets for

Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 99

Table 24: World Recent Past, Current & Future Analysis for

Porcine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 100

Table 25: World Historic Review for Porcine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 101

Table 26: World 11-Year Perspective for Porcine Vaccines by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 102

Table 27: World Recent Past, Current and Future Analysis for

Bovine Vaccines by Geographic Region - US, Europe & Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 103

Table 28: World Historic Review for Bovine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 104

Table 29: World 11-Year Perspective for Bovine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015(includes corresponding Graph/Chart) 105

Table 30: World Recent Past, Current & Future Analysis for

Poultry Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 106

Table 31: World Historic Review for Poultry Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 107

Table 32: World 11-Year Perspective for Poultry Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 108

Table 33: World Recent Past, Current & Future Analysis for

Ovine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 109

Table 34: World Historic Review for Ovine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 110

Table 35: World 11-Year Perspective for Ovine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015(includes corresponding Graph/Chart) 111

Table 36: World Recent Past, Current & Future Analysis for

Equine Vaccines by Geographic Region - US, Europe and Rest of

World Markets Independently Analyzed with Annual Sales Figures

in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 112

Table 37: World Historic Review for Equine Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 113

Table 38: World 11-Year Perspective for Equine Vaccines by

Geographic region - Percentage Breakdown of Dollar Sales for

US, Europe and Rest of World Markets for Years 2005, 2010 &

2015 (includes corresponding Graph/Chart) 114

Table 39: World Recent Past, Current & Future Analysis for

Other Animal Vaccines by Geographic Region - US, Europe and

Rest of World Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 115

Table 40: World Historic Review for Other Animal Vaccines by

Geographic Region - US, Europe and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 116

Table 41: World 11-Year Perspective for Other Animal Vaccines

by Geographic region - Percentage Breakdown of Dollar Sales

for US, Europe and Rest of World Markets for Years 2005, 2010&

2015 (includes corresponding Graph/Chart) 117

13. THE UNITED STATES 118

A.Market Analysis 118

Current & Future Analysis 118

H5N1 Virus: A Conundrum for the US Industry 118

Rabies Cases in the US 118

B.Market Analytics 119

Table 42: US Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 119

Table 43: US Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 120

Table 44: US 11-Year Perspective for Veterinary Vaccines by

Product Group/Segment - Percentage Breakdown of Dollar Sales

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 121

14. EUROPE 122

Market Analysis 122

Table 45: European Recent Past, Current & Future Analysis

for Veterinary Vaccines by Geographic Region - France,

Germany, Italy, United Kingdom and Rest of Europe Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2007 through 2015 (includes corresponding

Graph/Chart) 122

Table 46: European Historic Review for Veterinary Vaccines

by Geographic Region - France, Germany, Italy, United

Kingdom and Rest of Europe Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 123

Table 47: European 11-Year Perspective for Veterinary

Vaccines by Geographic Region - Percentage Breakdown of

Dollar Sales for France, Germany, Italy, United Kingdom and

Rest of Europe for Years 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 124

Table 48: European Recent Past, Current & Future for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 125

Table 49: European Historic Review for Veterinary Vaccines

by Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 126

Table 50: European 11-Year Perspective for Veterinary

Vaccines by Product Group/Segment - Percentage Breakdown of

Dollar Sales for Companion Animal Vaccines (Canine Vaccines

and Feline Vaccines) and Livestock Vaccines (Porcine

Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,

Equine Vaccines and Other Animal Vaccines) Markets for Years

2005, 2010 & 2015(includes corresponding Graph/Chart) 127

14a. FRANCE 128

Market Analysis 128

Table 51: French Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines and Equine Vaccines)

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 128

Table 52: French Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, and Equine Vaccines) Markets Independently

Analyzed with Annual Sales Figures in US$ Million for Years

2000 through 2006 (includes corresponding Graph/Chart) 129

Table 53: French 11-Year Perspective for Veterinary Vaccines

by Product Group/Segment - Percentage Breakdown of Dollar

Sales for Companion Animal Vaccines (Canine Vaccines and

Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine

Vaccines) Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 130

14b. GERMANY 131

Market Analysis 131

Table 54: German Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines and Equine Vaccines)

Markets Independently Analyzed with Annual Sales Figures in

US$ Million for Years 2007 through 2015 (includes

corresponding Graph/Chart) 131

Table 55: German Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines and Equine Vaccines) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2000

through 2006 (includes corresponding Graph/Chart) 132

Table 56: German 11-Year Perspective for Veterinary Vaccines

by Product Group/ Segment - Percentage Breakdown of Dollar

Sales for Companion Animal Vaccines (Canine Vaccines and

Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine

Vaccines) Markets for 2005, 2010 & 2015 (includes

corresponding Graph/Chart) 133

14c. ITALY 134

Market Analysis 134

Table 57: Italian Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 134

Table 58: Italian Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 135

Table 59: Italian 11-Year Perspective for Veterinary

Vaccines by Product Group/Segment - Percentage Breakdown of

Dollar Sales for Companion Animal Vaccines (Canine Vaccines

and Feline Vaccines) and Livestock Vaccines (Porcine

Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,

Equine Vaccines and Other Animal Vaccines) Markets for 2005,

2010 & 2015 (includes corresponding Graph/Chart) 136

14d. THE UNITED KINGDOM 137

Market Analysis 137

Table 60: UK Recent Past, Current & Future Analysis for

Veterinary Vaccines by Product Group/Segment - Companion

Animal Vaccines (Canine Vaccines and Feline Vaccines) and

Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,

Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other

Animal Vaccines) Markets Independently Analyzed with Annual

Sales Figures in US$ Million for Years 2007 through 2015

(includes corresponding Graph/Chart) 137

Table 61: UK Historic Review for Veterinary Vaccines by

Product Group/Segment - Companion Animal Vaccines (Canine

Vaccines and Feline Vaccines) and Livestock Vaccines

(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine

Vaccines, Equine Vaccines and Other Animal Vaccines) Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2000 through 2006 (includes corresponding

Graph/Chart) 138

Table 62: UK 11-Year Perspective for Veterinary Vaccines by

Product Group/Segment - Percentage Breakdown of Dollar Sales

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets for 2005, 2010 & 2015

(includes corresponding Graph/Chart) 139

14e. REST OF EUROPE 140

A.Market Analysis 140

Current & Future Analysis 140 A Note on Danish Veterinary

Services 140

The 2002 Standards of Danish Medicines recommend test for

antibody inducing fragments in veterinary vaccines 141

Hungary Vaccinates Birds Across Zoos 141

Russia Mass-Produces Vaccines Against Avian Flu 141

B.Market Analytics 142

Table 63: Rest of Europe Recent Past, Current & Future

Analysis for Veterinary Vaccines - by Product Group/ Segment

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 142

Table 64: Rest of Europe Historic Review for Veterinary

Vaccines by Product Group/Segment - Companion Animal

Vaccines (Canine Vaccines and Feline Vaccines) and Livestock

Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry

Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal

Vaccines) Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 143

Table 65: Rest of Europe 11-Year Perspective for Veterinary

Vaccines by Product/Segment - Percentage Breakdown of Dollar

Sales for Companion Animal Vaccines (Canine Vaccines and

Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,

Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine

Vaccines and Other Animal Vaccines) Markets for 2005, 2010 &

2015 (includes corresponding Graph/Chart) 144

15. REST OF WORLD 145

A.Market Analysis 145

Current & Future Analysis 145

Focus on Select Regions 145

Canada 145

Overview of Canadian Animal Health Industry 145

Import and Manufacture of Veterinary Biologics 145

First to Access E. coli 0157:H7 Vaccine 145

China 146

A Glance at the Animal Vaccine Market in China 146

China Initiates Mass Vaccination Campaign Against Bird Flu

Virus 147

Australia 147

A Note on Australian Veterinary Therapeutics Market 147

India 147

ICAR Develops Indigenous Bird Flu Vaccine 147

Thailand 147

Japan & Thailand to Cooperate for Developing Bird Flu Vaccine 147

Taiwan 148

Taiwan's Animal Healthcare Industry Under Scan 148

Malaysia 148

Malaysia Initiates Measures to Deal with Potential Flu

Pandemic 148

Kazakhstan 148

Kazakhstan Takes Proactive Measures Against Bird Flu 148

North Korea 149

North Korea Develops Bird Flu Vaccine 149

Vietnam 149

Vietnam Imports Bird Flu Vaccines 149

Egypt 149

Egypt Reports H5N1 Infection in Vaccinated Flocks 149

Kenya 149

Kenya Mass-Manufactures Vaccines Against Rift Valley Fever 149

B.Market Analytics 150

Table 66: Rest of World Recent Past, Current & Future

Analysis for Veterinary Vaccines - by Product Group/ Segment

for Companion Animal Vaccines (Canine Vaccines and Feline

Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine

Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines

and Other Animal Vaccines) Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2007

through 2015 (includes corresponding Graph/Chart) 150

Table 67: Rest of World Historic Review for Veterinary

Vaccines by Product Group/Segment - Companion Animal

Vaccines (Canine Vaccines and Feline Vaccines) and Livestock

Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry

Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal

Vaccines) Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2000 through 2006 (includes

corresponding Graph/Chart) 151

Table 68: Rest of World 11-Year Perspective for Veterinary

Vaccines by Product Group/Segment - Percentage Breakdown of

Dollar Sales for Companion Animal Vaccines (Canine Vaccines

and Feline Vaccines) and Livestock Vaccines (Porcine

Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,

Equine Vaccines and Other Animal Vaccines) Markets for 2005,

2010 & 2015 (includes corresponding Graph/Chart)152

COMPETITIVE LANDSCAPE

Total Companies Profiled: 69 (including Divisions/Subsidiaries - 97)

------------------------------------------

Region/Country Players

------------------------------------------

The United States 30

Canada 5

Japan 3

Europe 28

France 3

Germany 8

The United Kingdom 1

Italy 2

Rest of Europe 14

Asia-Pacific (Excluding Japan) 22

Latin America 5

Africa 1

Middle-East 3

------------------------------------------

To order this report:

: Global Veterinary Vaccines Industry

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com